Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.7990
+0.0070 (0.88%)
At close: Oct 9, 2026, 4:00 PM EDT
0.7900
-0.0090 (-1.13%)
After-hours: Oct 9, 2026, 7:30 PM EDT
RANI Market Cap
RANI has a market cap or net worth of $111.38 million as of October 9, 2026. It is the 24,687th most valuable company in the world and the 4,034th biggest in the United States. Its market cap has increased by 374.45% in one year.
Market Cap
111.38M
Enterprise Value
61.53M
1-Year Change
374.45%
Global Rank
Country Rank
#4,034 United States
Category
ChartMarket Cap Chart
Since the IPO on July 30, 2021, RANI's market cap has decreased from $206.13M to $111.38M, a decrease of -45.97%. That is a compound annual growth rate of -11.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 92.22M | -29.97% |
| Dec 31, 2025 | 131.69M | 188.57% |
| Dec 31, 2024 | 45.64M | -46.89% |
| Dec 29, 2023 | 85.92M | -41.09% |
| Dec 30, 2022 | 145.85M | -54.75% |
| Dec 31, 2021 | 322.29M | 56.36% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Coya Therapeutics | 117.05M |
| Unicycive Therapeutics | 113.37M |
| Inovio Pharmaceuticals | 112.70M |
| PMV Pharmaceuticals | 112.51M |
| Genelux | 112.03M |
| Tevogen | 111.10M |
| Vivani Medical | 110.95M |
| LENZ Therapeutics | 110.91M |